A small company can now advance its psychedelic into Phase 3. Here’s why that matters to other psychedelic biotechs.
Dow Jumps 800 Points; ISM Manufacturing PMI Falls In December - GH Research (NASDAQ:GHRS), Momentus (NASDAQ:MNTS)